Logo 6 a1e69dad97a22b9caa5aa6c606f6ea7f9e9b8c4d0352141ae8a7e9bed5512ee3
  • Antibodies
  • Assays/Kits
  • Proteins/Peptides
  • siRNAs/Functional Genomics
  • Biochemicals
  • cDNA Clones
  • Cell/Tissue/Blood Products
  • Genes
  • Images

ARRY 520 trifluoroacetate

Name ARRY 520 trifluoroacetate
Supplier R&D Systems
Catalog 4676
Prices $225.00
Sizes 10 mg
Cas Number 885060-09-3
Chemical Name (2S)-2-(3-Aminopropyl)-5-(2,5-difluorophenyl)-N-methoxy-N-methyl-2-phenyl-1,3,4-thiadiazole-3(2H)-carboxamidetrifluoroacetate
Formula C20H22F2N4O2S.CF3CO2H
Molecular Weight 420.48
Purity >98%
Supplier Page Shop

Product References

KSP inhibitor ARRY-520 as a substitute for Paclitaxel in Type I ovarian cancer - KSP inhibitor ARRY-520 as a substitute for Paclitaxel in Type I ovarian cancer

Kim KH, Xie Y, Tytler EM, Woessner R, Mor G, Alvero AB. J Transl Med. 2009 Jul 20;7:63.

ARRY-520, a novel KSP inhibitor with potent activity in hematological and - ARRY-520, a novel KSP inhibitor with potent activity in hematological and

Woessner R, Tunquist B, Lemieux C, Chlipala E, Jackinsky S, Dewolf W Jr, Voegtli W, Cox A, Rana S, Lee P, Walker D. Anticancer Res. 2009 Nov;29(11):4373-80.

Mcl-1 stability determines mitotic cell fate of human multiple myeloma tumor - Mcl-1 stability determines mitotic cell fate of human multiple myeloma tumor

Tunquist BJ, Woessner RD, Walker DH. Mol Cancer Ther. 2010 Jul;9(7):2046-56.



Privacy
Terms
About us
Contact us

Copyright© 2025. All Rights Reserved